Mandom Corporation
Mandom Corporation (4917.T) Financial Performance & Income Statement Overview
Explore the financials of Mandom Corporation (4917.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Mandom Corporation (4917.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Mandom Corporation 4917.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $19.05B | $17.95B | $19.92B | $19.27B |
| Cost of Revenue | $10.54B | $10.17B | $11.69B | $11.03B |
| Gross Profit | $8.51B | $7.85B | $8.23B | $8.24B |
| Gross Profit Ratio | $0.45 | $0.44 | $0.41 | $0.43 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.82B | $7.95B | $7.49B | $7.54B |
| Operating Expenses | $8.82B | $7.88B | $7.49B | $7.54B |
| Total Costs & Expenses | $19.36B | $18.05B | $19.18B | $18.57B |
| Interest Income | $163.00M | $0.00 | $131.00M | $133.00M |
| Interest Expense | $7.00M | $0.00 | $8.00M | $11.00M |
| Depreciation & Amortization | $1.10B | $1.06B | $1.06B | $1.04B |
| EBITDA | $1.23B | $965.00M | $1.80B | $1.74B |
| EBITDA Ratio | $0.06 | $0.05 | $0.09 | $0.09 |
| Operating Income | -$307.00M | -$97.00M | $736.00M | $696.00M |
| Operating Income Ratio | -$0.02 | -$0.005 | $0.04 | $0.04 |
| Other Income/Expenses (Net) | $432.00M | $179.00M | $336.00M | $322.00M |
| Income Before Tax | $125.00M | $82.00M | $1.07B | $1.02B |
| Income Before Tax Ratio | $0.007 | $0.005 | $0.05 | $0.05 |
| Income Tax Expense | $154.00M | -$5.00M | $223.00M | $408.00M |
| Net Income | $39.00M | $258.00M | $896.00M | $666.00M |
| Net Income Ratio | $0.002 | $0.01 | $0.04 | $0.03 |
| EPS | $0.86 | $5.72 | $19.91 | $14.81 |
| Diluted EPS | $0.86 | $5.72 | $19.91 | $14.81 |
| Weighted Avg Shares Outstanding | $45.14M | $45.14M | $45.006M | $44.96M |
| Weighted Avg Shares Outstanding (Diluted) | $45.14M | $45.14M | $45.006M | $44.96M |
The company's financials show resilient growth, with revenue advancing from $19.27B in Q1 2024 to $19.05B in Q4 2024. Gross profit remained healthy with margins at 45% in Q4 2024 compared to 43% in Q1 2024. Operating income hit -$307.00M last quarter, sustaining a consistent -2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.23B. Net income dropped to $39.00M, while earnings per share reached $0.86. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan